A full list of Jennifer Donegan’s publications can be found on NCBI My Bibliography.

2026
Maternal Immune Activation Leads to Mitochondrial Dysfunction and a Social Deficit in Offspring That Is Reversed by Nicotinamide Riboside.

Bazhin, A.A., Solodnikova, E.S., San Miguel, D.A., Dantzer, R., Ghouri, Y.A., Donegan, J.J., Goun, E. Nutrients, 2026, 18(6):889.

2024
Knockdown of Lhx6 during embryonic development results in neurophysiological alterations and behavioral deficits analogous to schizophrenia in adult rats.

Elam, H.B., Perez, S.M., Donegan, J.J., Eassa, N.E., Lodge, D.J. Schizophrenia Research, 2024, 267:113-121.

2023
Discrete hippocampal projections are differentially regulated by parvalbumin and somatostatin interneurons.

Lodge, D.J., Elam, H.B., Boley, A.M., Donegan, J.J. Nature Communications, 2023, 14(1):6653.

2020
Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia.

Donegan, J.J., Boley, A.M., Carless, M.A., Lodge, D.J. PLoS One, 2020, 15(6):e0232200.

2020
Stem cells for improving the treatment of neurodevelopmental disorders.

Donegan, J.J. and Lodge, D.J. Stem Cells in Development, 2020, 29(17):1118.

2019
Modulation of extrasynaptic GABA A alpha 5 receptors in the ventral hippocampus normalizes physiological and behavioral deficits in a circuit specific manner.

Donegan, J.J., Boley, A.M., Yamaguchi, Y., Toney, G.M., and Lodge, D.J. Nature Communications, 2019, 10(1):2819.

2018
Embryonic stem cell transplants as a therapeutic strategy in a rodent model of autism.

Donegan, J.J., Boley, A.M., and Lodge, D.J. Neuropsychopharmacology, 2018, 43(8):1789-1798.

2017
Cell-based therapies for the treatment of schizophrenia.

Donegan, J.J. and Lodge, D.J. Brain Research, 2017, 1655:262-269.

2017
Stem cell derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent model.

Donegan, J.J., Tyson, J.A., Branch, S.Y., Beckstead, M.J., Anderson, S.A., Lodge, D.J. Molecular Psychiatry, 2017, 22(10):1492-1501.